Popeyes’ sandwich sells out, Forever 21 ponders bankruptcy, and Marriott to discontinue tiny toiletries

Good morning, PR pros:

The recent $527 million ruling against Johnson & Johnson for its role in Oklahoma’s opioid crisis has begun a domino effect among other pharmaceutical companies.

NPR reported:

Confronted with a torrent of lawsuits across the U.S., several major drug companies are in discussions with authorities to resolve thousands of opioid-related suits filed against them. A government source close to the negotiations tells NPR that Purdue Pharma, Johnson & Johnson, Endo International and Allergan are looking to cut deals.